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The aim of the present study was to compare the clinical findings
and polysomnography results obtained at public and private clin-
ics in Brazil, the follow-up after diagnosis, and the therapeutic
aspects related to continuous positive airway pressure. Patients
who snore and who have obstructive sleep apnea were retrospec-
tively divided into two groups, i.e., public clinic (N = 307) and
private clinic (N = 317). Data concerning age, sex, body mass index
(BMI), neck circumference, medical history, sleepiness scale, fol-
low-up after diagnosis, and acceptance of continuous positive
airway pressure therapy were collected. Mean age was 50 ± 12
(range: 15-80) for public patients and 48 ± 12 years (range: 19-91)
for private patients. Mean BMI was 30 ± 6 (range: 19-67) for public
patients and 31 ± 6 kg/m2 (range: 21-59) for private patients. The
public clinic had a significantly higher frequency of women than
the private clinic (M:F ratio of 2.0:1 and 6.9:1, respectively). The
condition of private patients (apnea-hypopnea index = 31 ± 25) was
more severe than that of public patients (apnea-hypopnea index =
25 ± 24 events/h; P = 0.0004). In the public and private clinics, 19
and 15% of patients were snorers, respectively, and 81 and 85% of
them had sleep apnea. After diagnosis, follow-up was longer in the
private group. The continuous positive airway pressure accep-
tance was similar for both groups (32 vs 35%), but patients from the
public clinic abandoned treatment more than private ones (65 vs
13%). Social status was significant in terms of the severity of
obstructive sleep apnea age and gender distribution. Private pa-
tients look for a diagnosis earlier in the course of the disease than
public patients, adhere more to follow-up, and abandon continuous
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Obstructive sleep apnea (OSA) is consid-
ered to be a medical and public health prob-
lem in terms of its consequences for the
cardiovascular system (high blood pressure
and ischemic heart disease) and excessive
daytime sleepiness (causing automobile acci-
dents), affecting mainly obese middle-aged
individuals (1-4). Since OSA was first de-
scribed by Guilleminault et al. (5), some
therapeutic modalities have been adopted
such as tracheostomy, weight loss, upper
airway surgeries, oral appliances, and con-
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tinuous positive airway pressure (CPAP) (6).
The use of CPAP is one of the most common
treatments for patients with OSA since its
efficacy for the improvement of quality of
life has been well demonstrated (7,8). The
clinical and polysomnography (PSG) fea-
tures of OSA patients are well-known in the
literature, as also are the indication of and
compliance with nasal CPAP (9-11). Some
individual aspects such as obesity, gender,
age, ethnicity, smoking, and alcohol use are
closely related to OSA (12-18). Demographic
data, clinical findings, PSG features, and
CPAP acceptance have not been previously
compared between public and private clin-
ics. Patients from these clinics mainly differ
in economic status, a fact that can be highly
relevant in terms of the principal treatment
of sleep apnea considering the high cost of
nasal CPAP.
We hypothesize that patients from public
and private clinics differ not only in severity
of apnea-hypopnea index (AHI) but also in
social aspects that might influence treatment
with nasal CPAP. The objectives of the pres-
ent study were: 1) to compare clinical find-
ings and PSG results between public and
private clinics, and 2) to compare the follow-
up after diagnosis of OSA and the therapeu-
tic aspects related to nasal CPAP between
these groups of patients in Brazil.
Material and Methods
Study subjects
All data were retrospectively collected from
patient charts at the Sleep Clinic of Universi-
dade Federal de São Paulo, that attends pa-
tients referred from the public university hos-
pital and from a private clinic. A total of 624
adult snorers or OSA patients seen from
1997 to 2000 were divided into two groups,
namely public clinic (N = 307) and private
clinic (N = 317). The inclusion criterion was
adult patients with OSA (including snorers
without apnea) evaluated by PSG.
Clinical evaluation
Our Sleep Laboratory is a national refer-
ence center staffed by a multidisciplinary
group, and the physicians responsible for the
respiratory sleep disorders use the same stan-
dardized questionnaire to evaluate both pub-
lic and private patients. The data collected
from the charts were age, sex, body mass
index (BMI), neck circumference, past and
present medical history, Epworth Sleepiness
Scale (ESS), follow-up after diagnosis, and
acceptance of CPAP therapy. Medical his-
tory included presence of hypertension, car-
diovascular diseases (myocardial infarction,
coronary heart disease, arrhythmia, heart fail-
ure, and cerebrovascular accident), asthma,
diabetes mellitus, hypothyroidism, nasal ob-
struction, and nasal allergic symptoms (sneez-
ing, nasal itching, rhinorrhea).
Polysomnography monitoring
PSG was performed for one full night
using a 13-channel SAC Oxford® system
(version 10, Oxford Instruments, Inc., Tampa,
FL, USA) for the determination of electro-
cardiogram, oculogram, submental and an-
terior tibialis electromyogram, nasal and oral
airflow (measured with a thermistor), tho-
racic and abdominal movements, body posi-
tion, and oxygen saturation measured by
pulse oximetry. The sleep stages were scored
according to the Rechstaffen and Kales
Manual (19), arousal according to ASDA
recommendations (20), and respiratory events
according to AASM (21) recommendations.
Statistical analysis
Statistically significant differences be-
tween public and private patients were deter-
mined by the Mann-Whitney U-test or the
chi-square test for two independent samples,
depending on the type of the variable. For all
tests, the level of significance was set at P ≤
0.05. Data were analyzed using Statistics for
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Windows software, release 5.1 (Statsoft
Inc., 1997).
Results
The data comparing public to private
patients revealed a mean age of 50 ± 12 and
48 ± 12 years (P = 0.014), BMI of 30 ± 6 and
31 ± 6 kg/m2, neck circumference of 41 ± 5
and 43 ± 4 cm, respectively, with a predomi-
nance of men in both groups, and with the
private clinic having a higher percent of men
than the public (87 and 67%, respectively, P
< 0.0001) (Table 1). The public clinic had a
significantly higher frequency of women than
the private clinic, with male:female ratios of
2.0:1 for public clinic and 6.9:1 for private
clinic. When the groups were divided ac-
cording to age decade, the majority of pa-
tients in both clinics were found to be con-
centrated between the 4th and 5th decade
(Figure 1). The groups differed significantly
in the distribution of age decade, with more
private than public patients in the 3rd decade
and more public than private patients in the
6th decade. Considering the degrees of obe-
sity, the public and private clinics were
closely similar, and most patients were con-
centrated in the mild and moderate catego-
ries of obesity in both groups. Among all
patients (snorers and OSA patients), the ba-
sal PSG study showed a mean AHI of 25 ± 24
and 31 ± 25 events/h for the public and
private clinics (P = 0.0004), respectively,
and a lowest oxygen saturation of 78 ± 12
and 74 ± 13% (P = 0.0003). According to the
sleep questionnaire, private patients were
similar, with a mean ESS score of 12 ± 8 and
13 ± 6.
In the past medical history of the public
and private groups, hypertension was the
major health problem without a significant
difference between groups, affecting 36% of
public patients and 34% of private patients.
Hypothyroidism, diabetes mellitus, asthma,
and cardiovascular diseases were present at
low frequency in both groups, and diabetes
Table 1. Anthropometric and polysomnography data, Epworth Sleepiness Scale, and
past medical history of private and public clinic patients.
Public clinic (N = 307) Private clinic (N = 317)
Age (years) 50 ± 12 48 ± 12*
BMI (kg/m2) 30 ± 6 31 ± 6
Neck circumference (cm) 41 ± 5 43 ± 4
Gender (% males:% females) 67:33 87:13*
ESS 12 ± 8 13 ± 6
Basal AHI (events/h) 25 ± 24 31 ± 25*
Lowest O2 saturation (%) 78 ± 12 74 ± 13*
Hypertension 36% 34%
Hypothyroidism 3% 2%
Diabetes mellitus 9% 3%*
Asthma 5% 6%
Cardiovascular diseases 6% 7%
AHI = apnea-hypopnea index; BMI = body mass index; ESS = Epworth Sleepiness
Scale; N = number of patients.
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Figure 1. Patient distribution between public and private clinics according to age (2nd: up to
29 years; 3rd: between 30 and 39 years; 4th: between 40 and 49 years; 5th: between 50
and 59 years; 6th: between 60 and 69 years; >7th: 70 years and over). *P = 0.019 for 3rd
decade and P = 0.033 for 6th decade of age (chi-square test).
mellitus was more frequent among public
clinic patients. The anthropometric and PSG
data, ESS and medical history of both groups
are summarized in Table 1.
On the basis of AHI score, the patients
were classified as snorers without apnea (AHI
<5), with mild sleep apnea (AHI = 5-15),
moderate sleep apnea (AHI = 15-30) or se-
vere disease (AHI >30) (21). According to
this classification, the groups were signifi-
cantly different in terms of the severe apnea
category, with the private clinic having more
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severe patients than the public clinic (P =
0.002; Figure 2). In the public and private
clinics, 19 and 15% of patients, respectively,
were considered to be snorers (AHI <5), and
81 and 85% of them had some degree of
sleep apnea (AHI >5), representing the great
majority in both groups, without a signifi-
cant difference between them.
According to the charts, part of the pa-
tients in each group had been questioned
about nasal symptoms (obstruction or al-
lergy), i.e., 67.1% of public patients (N =
209/307) and 74.4% of private patients (N =
236/317). Considering just patients who were
questioned about nasal symptoms, 75.6% of
those in the public group (N = 158/209) and
58.1% of those in the private group (N = 137/
236; P = 0.001) reported a past history of
nasal symptoms. Nasal obstruction was the
most common symptom, followed by sneez-
ing and nasal itching.
After diagnosis by PSG, the return for a
new schedule was higher in the private group,
79 vs 68% (P = 0.002) (Table 2). A new PSG
to evaluate CPAP titration and its therapeutic
results was performed in 35% (107/307) of
public patients and in 43% (N = 136/317) of
private patients (P = 0.039). Among patients
who performed CPAP titration, 32% in the
public clinic and 35% in the private clinic
started to use CPAP. The status of CPAP
acceptance (i.e., patients who started to use
nasal CPAP) was closely similar in both
groups, but a large part of patients from the
public clinic abandoned treatment (65 vs 13,
P < 0.0001).
Among the patients using nasal CPAP,
the public and private clinics differed in the
severity of sleep apnea, with private patients
being more severe than public ones, with
AHI of 51 ± 23 and 42 ± 28 events/h (P =
0.009; Table 3). Patients using nasal CPAP
did not differ in terms of symptoms of nasal
obstruction or ESS score. Considering only
the patients that stopped using CPAP, the
difference between the two groups was about
apnea severity but this difference was not
statistically significant.
Discussion
The study outcome demonstrated that
patients in the 4th and 5th decades of life
predominated in both groups, but patients
from the private clinic were slightly younger
than those from the public clinic. According
to the literature, OSA mainly occurs in
middle-aged adults and tends to become
worse and more prevalent with age (22,23).
After the peak between the 4th and 5th de-
cades of age, the distribution showed a de-
cline in the frequency of patients over 60
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Figure 2. Patient distribution according to AHI classification between public and private
clinics (without apnea: AHI <5; mild: AHI = 5-15; moderate: AHI = 15-30; severe: AHI >30
events/h). AHI = apnea-hypopnea index. *P = 0.002 compared to severe apnea public clinic
patients (chi-square test).
Table 2. Comparison of follow-up after diagnosis and of CPAP impact between the
public and private clinic patients.
Public clinic Private clinic Odds ratio
(N = 307) (N = 317)  95% CI (range)
Return after OSA diagnosis 68% (209/307) 79% (251/307)* 0.56 (0.38-0.81)
PSG with CPAP 35% (107/307) 43% (136/317)* 0.71 (0.50-0.99)
Started CPAP treatment 32% (34/107) 35% (47/136) 0.88 (0.40-1.56)
Stopped CPAP treatment 65% (22/34) 13% (6/47)* 12.52 (3.68-44.92)
CI = confidence interval; CPAP = continuous positive airway pressure; OSA = obstruc-
tive sleep apnea; PSG = polysomnography.
*P < 0.05 compared to public clinic patients (chi-square test).
*
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represent a low life expectancy for both
groups. Lindberg et al. (12) observed this
situation in a study of 2,668 men aged 30-69
years followed up for 10 years. The preva-
lence of apnea in this series increased up to
50-60 years and was followed by a decrease
thereafter. This situation reflects the need to
diagnose patients with OSA at the youngest
possible age for early treatment, with a pos-
sible consequent change in the impact of
mortality. The influence of OSA on mortal-
ity was reported by some investigators and is
related to the severity of apnea as well as to
patient age (24-26). The probability of sur-
vival is higher in less severe patients and age
seems to influence mortality only in patients
below the age of 50 according to the study by
He et al. (24) and, just below the age of 60
according to the study by Lindberg et al.
(26).
The typical patient with OSA is described
as an overweight adult male and some stud-
ies have shown the important influence of
obesity (13,15). In our study, close to 88% of
all patients in the public and private clinics
were overweight. Most patients had a BMI
between 26 and 40 kg/m2 and only a few of
them had morbid obesity. The weight distri-
bution was not influenced by social class in
the patients studied.
As expected, a high predominance of
males was noted in both groups, but the
public clinic had a higher frequency of
women than the private one, with respective
M:F ratios of 2.0:1 for public clinic and 6.9:1
for private clinic. One hypothesis for the
gender disparity observed between public
and private patients in our study is that women
from the private clinic may be under-diag-
nosed, perhaps because they do not feel so
comfortable to admit that they snore and so
do not seek medical care. When the patients
from the two clinics were classified accord-
ing to gender and age, an interesting distri-
bution was observed (Figure 3). Considering
the percentage of patients for each decade of
age, there was a different distribution be-
tween men and women in the 3rd and 5th
decades of life for public patients. Figure 3
shows an increase in the percentage of women
from the 4th to the 5th decade of life, which
might correspond to the menopausal period,
when women present a higher incidence of
sleep apnea. However, we did not observe
the same occurrence in the distribution of
private patients, with a difference being ob-
served only in the 4th decade of life without
an increase in the percentage of women com-
Figure 3. Patient distribution ac-
cording to age and gender clas-
sification for public (A) and pri-
vate clinics (B) (2nd: up to 29
years; 3rd: between 30 and 39
years; 4th: between 40 and 49
years; 5th: between 50 and 59
years; 6th: between 60 and 69
years; >7th: 70 years and over).
*P < 0.05 compared to women
(chi-square test).
Table 3. Comparison of patients from public and
private clinics who started to use CPAP.
Public clinic Private clinic
(N = 34) (N = 47)
AHI 42 ± 28 51 ± 23*
Mild apnea 6% (2) 2% (1)
Moderate apnea 41% (14) 11% (5)*
Severe apnea 53% (18) 87% (41)*
ESS 13 ± 6 14 ± 6
AHI of patients who 40 ± 28 56 ± 22
stopped using CPAP
AHI = apnea-hypopnea index; CPAP = continuous
positive airway pressure; ESS = Epworth Sleepi-
ness Scale; N = number of patients.
*P < 0.05 compared to public clinic patients (Mann-
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pared to the 3rd decade of life.
One question that has not been fully
answered is why men are more prevalent
than women. Could this be related to the
pathology of OSA, to which men are more
susceptible? Or could it be that women are
not well diagnosed and we are missing them?
Young et al. (27) have shown that current
clinical indications to evaluate OSA are as
appropriate for women as they are for men.
Considering men and women with the same
level of AHI, they did not find different
reported symptoms between them, and snor-
ing was the most sensitive and strongest
predictor of sleep apnea for both sexes. The
difference in prevalence between men and
women seems to decrease during the post-
menopausal period when weight gain and
central obesity are observed, also associated
with aging (28).
In the public and private clinics studied
here, 15 to 19% of subjects had snoring
without apnea (AHI <5) and 81 to 85% of
them, i.e., the great majority in both groups,
had some degree of sleep apnea (AIH >5).
Considering the severity of OSA, private
clinic patients had a more severe condition
according to AIH and also to lowest O2
saturation. However, this cannot be explained
by BMI because the groups had a closely
similar BMI distribution, or by age since the
most severe group comprised slightly younger
patients. It was observed that the gender
ratio was different between these two groups.
Considering male and female AHI for both
private (male AHI = 32 ± 25 and female AHI
= 21 ± 21; P = 0.001) and public (male AHI
= 28 ± 26 and female AHI = 19 ± 21; P =
0.0001) patients, it is possible to observe
that women had a less severe condition in
both groups. The fact that among public
patients there was a higher proportion of
women than among private patients, and
women had a less severe condition can ex-
plain, at least in part, why public patients had
a less severe condition according to AHI.
When past medical history was checked, the
only difference was a higher frequency of
diabetes mellitus among public patients, pos-
sibly related to the fact that public patients
were older and so had a higher probability to
develop diabetes mellitus. The only differ-
ence that could influence the severity was
that private patients included more males
than public ones.
A past history of nasal symptoms was
more frequent at both clinics, but was even
more frequent in the public group (75.6 vs
58.1%), with more than half of all patients
usually reporting some nasal problem. These
data should be considered with caution since
the numbers were collected retrospectively
from the charts, where it was more likely that
the physicians would record positive symp-
toms more than negative ones. According to
the literature, 21.9 to 66% of patients using
nasal CPAP usually report some nasal symp-
toms (29-32). In our study, nasal obstruction
was the major problem for both clinics but
was more frequent among private patients.
With respect to the return after the OSA
diagnosis, private patients complied with
follow-up more than public patients. The
private clinic had more severe patients ac-
cording to the AHI and the lowest O2 satura-
tion, a fact that could explain why their
patients came back for follow-up and per-
formed PSG with CPAP more than public
patients. In Brazil, all the investigation with
PSG is supported by the Health Care Agen-
cies or by Public Hospitals, but these organs
do not provide CPAP devices for the pa-
tients. Public and private clinics did not dif-
fer in the acceptance of CPAP treatment
(patients who started to use nasal CPAP). In
our Sleep Laboratory, public and private
clinics receive the same CPAP educational
program provided by the same staff. How-
ever, the group of public patients using nasal
CPAP had a less severe condition consider-
ing the AHI and more than half of them
stopped using nasal CPAP (Tables 2 and 3).
The daytime sleepiness symptom, according
to ESS score, was similar for patients using
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nasal CPAP. Among the patients who stopped
using CPAP, public patients tended to show
a milder degree of apnea than private pa-
tients although the difference was nonsig-
nificant. The fact that their illness was milder
may explain, at least in part, why public
patients abandoned CPAP more frequently
than private patients.
Social status did not influence BMI, neck
circumference or ESS, but was of clinical
significance in terms of OSA severity (pa-
tients from the private clinic had a more
severe condition) and of gender distribution
(the public clinic had three times more women
than the private clinic). Also, private patients
were younger than public patients. Nearly
60% of both private and public clinics re-
ported a past history of nasal symptoms.
Obesity was highly prevalent in both clinics,
but a minority of patients had morbid obesity.
Considering the investigation and treat-
ment of OSA, private patients sought a diag-
nosis earlier than public ones, came back for
follow-up more than public patients did, and
abandoned CPAP treatment much less than
public ones. Our data indicate that public
health programs are needed to improve the
use of nasal CPAP by less privileged social
class patients and to reduce the occurrence
of ineffective treatment.
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